IL22 and myelodysplastic syndrome: No significant difference of PB IL-22 level between MDS patients (median, 22.64 pg/ml; range, 16.02–54.66) and normal controls (median, 23.86 pg/ml; range, 14.05–36.49) was observed, consistent with BM findings (Fig. 3 A, C).